Skip to menu Skip to content Skip to footer
Professor Simon Cool
Professor

Simon Cool

Email: 
Phone: 
+61 7 336 54175

Overview

Background

Professor Simon Cool is Professor of Bioengineering and Director of the UQ Advanced Cell Therapy Manufacturing Initiative in the School of Chemical Engineering at the University of Queensland.

Professor Cool began his scientific career at the University of Queensland more than 20 years ago. He received his BSc (hons) and PhD degrees from the University of Queensland, where he subsequently held a faculty position in the School of Biomedical Sciences. His areas of studies have included age-related changes in the structure of bone and teeth and the extracellular matrix compartment of skeletal tissue that guide stem cell behaviour and wound repair. Professor Cool was invited to join the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore in 2003 as a Principal Investigator. He then joined A*STAR’s Institute of Medical Biology (IMB) in 2008, shortly after its inception, to further his research in regenerative medicine, serving as Senior Principal Investigator of the Glycotherapeutics Group. In October 2020, Professor Cool re-joined the Institute of Molecular and Cell Biology (IMCB) as a Research Director, Glycotherapeutics, where he focused on developing novel glycosaminoglycan biomolecules that enhance wound repair and control adult human mesenchymal stem cell activity.

Professor Cool has 117 patent applications across 26 families with 51 granted in the fields of glycosaminoglycan biochemistry, regenerative medicine and stem cell science. He has more than 150 publications and continues to foster strong strategic collaborations both nationally and internationally with academic and industry groups. He has a strong biomanufacturing and translational focus with experience in taking glycosaminoglycan-based devices through discovery RnD on to pre-clinical and clinical testing. Professor Cool also has an entrepreneurial and licensing background having successfully spun-off some of his technology to a US-based regenerative medicine start-up company, SMC Biotechnology Ltd. Professor Cool holds a Visiting Professor appointment at the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore and an Adjunct Professor (Research) appointment in the Orthopaedic Department at the National University of Singapore (NUS). Prior to his move back to UQ, he previously held the position of Treasurer, Tissue Engineering and Regenerative Medicine International Society, Asia Pacific Chapter (TERMIS-AP) and Treasurer, Stem Cell Society Singapore (SCSS). He also held senior leadership positions in several Singapore-based R&D programmes, notably as Director, Allogeneic Stem Cell Manufacturing (ASTEM) and Theme Leader in Advanced Manufacturing for Biological Materials (AMBM). Prof Cool currently serves on the Editorial Board of the journals Biomaterials, Tissue Engineering and Regenerative Medicine, and is Asia-Pacific Regional Editor for Stem Cells and Development.

Availability

Professor Simon Cool is:
Available for supervision

Qualifications

  • Bachelor of Science (Honours), unknown
  • PhD, unknown

Research interests

  • Manufacturing highly-potent stem cells

    Developing novel media, assays, and processes to enable the scale-up manufacturing of cell therapy products.

  • Rejuvenation of ageing stem cells

    Developing innovative methods to rejuvenate ageing stem cells to generate best-in-class cell banks for therapeutic use.

  • Synthesis of glycosaminoglycans as medical devices

    Developing scalable methods to manufacture fully synthetic glycosaminoglycans for use as media additives, biocoatings and medical devices for treating disease, injury or trauma.

  • Modification of stem cells to improve their therapeutic utility

    Altering stem cell surfaces to encourage protein binding and drive stem cell fate decisions for improved therapeutic efficacy.

  • Enhanced angiogenesis through glycosaminoglycan administration and medical device formulation

    Developing pro-angiogenic microenvironments using novel glycosaminoglycan formulations.

Research impacts

I have over 25 years of leadership in identifying novel heparan sulphate (HS) glycosaminoglycan (GAG) sugars within stem cell niches and repairing tissues. These sugars sequester, protect, hold, and present key growth factors to stem cells. I have successfully used this complexation paradigm to unlock pathways critical to stem cell biology, mainly signalling cascades essential for maintaining naïve phenotypes. I have also shown that this strategy effectively develops bioadditives for manufacturing cell therapy devices for treating vascular ischemia/stroke, cartilage regeneration, and bone repair. A significant part of this pioneering effort has been manufacturing HS variants that mimic sugars in native tissues. Anchoring this strategy is my novel discovery platform that identifies specific domains in HS chains that form complexes with growth factors and growth factor receptors to generate powerful signalling complexes that mediate cell-fate decisions and potentiate tissue regeneration. Using this blueprint, I have developed a library of bio-inspired HS variants and subjected them to structure/function analyses. I strongly advocate for the safety/tolerability testing of HS materials and continue to lead industry-based projects in this area. I have considerable experience leading outcome-focused multidisciplinary research teams across all scientific discovery and translation aspects, with a proven track record in developing transformative technology and biotechnology entrepreneurship. I lead a long-standing effort to bank mesenchymal stem cells cultured in HS-supplemented media to treat age-related diseases (pre-clinical stage only) and have been working to transition this project to a commercial facility to develop suitable manufacturing and banking protocols for future clinical testing. Through these various opportunities, I have mentored numerous PhD students in Australia, Singapore, and the UK, which has helped accelerate research opportunities and led to significant gains in generating novel findings.

Works

Search Professor Simon Cool’s works on UQ eSpace

164 works between 1996 and 2024

61 - 80 of 164 works

2015

Conference Publication

High-throughput microfluidic screening of human mesenchymal Stem Cell proliferative responses to FGF-2 and heparan sulfates

Titmarsh, D., Glass, N., Nurcombe, V., Cooper-White, J. and Cool, S. (2015). High-throughput microfluidic screening of human mesenchymal Stem Cell proliferative responses to FGF-2 and heparan sulfates. 4th TERMIS World Congress, Boston, MA USA, 8-11 September 2015. New Rochelle, NY USA: Mary Ann Liebert.

High-throughput microfluidic screening of human mesenchymal Stem Cell proliferative responses to FGF-2 and heparan sulfates

2015

Journal Article

Establishing criteria for human mesenchymal stem cell potency

Samsonraj, Rebekah M., Rai, Bina, Sathiyanathan, Padmapriya, Puan, Kia Joo, Rötzschke, Olaf, Hui, James H., Raghunath, Michael, Stanton, Lawrence W., Nurcombe, Victor and Cool, Simon M. (2015). Establishing criteria for human mesenchymal stem cell potency. Stem Cells, 33 (6), 1878-1891. doi: 10.1002/stem.1982

Establishing criteria for human mesenchymal stem cell potency

2014

Journal Article

Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity

Okolicsanyi, Rachel K., Van Wijnen, Andre J., Cool, Simon M., Stein, Gary S., Griffiths, Lyn R. and Haupt, Larisa M. (2014). Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity. Journal of Cellular Biochemistry, 115 (5), 967-976. doi: 10.1002/jcb.24746

Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity

2014

Journal Article

Engineering a vascular endothelial growth factor 165-binding heparan sulfate for vascular therapy

Wang, Chunming, Poon, Selina, Murali, Sadasivam, Koo, Chuay-Yeng, Bell, Tracey J., Hinkley, Simon F., Yeong, Huiqing, Bhakoo, Kishore, Nurcombe, Victor and Cool, Simon M. (2014). Engineering a vascular endothelial growth factor 165-binding heparan sulfate for vascular therapy. Biomaterials, 35 (25), 6776-6786. doi: 10.1016/j.biomaterials.2014.04.084

Engineering a vascular endothelial growth factor 165-binding heparan sulfate for vascular therapy

2014

Journal Article

New strategies for cartilage regeneration exploiting selected glycosaminoglycans to enhance cell fate determination

Ayerst, Bethanie I., Day, Anthony J., Nurcombe, Victor, Cool, Simon M. and Merry, Catherine L.R. (2014). New strategies for cartilage regeneration exploiting selected glycosaminoglycans to enhance cell fate determination. Biochemical Society Transactions, 42 (3), 703-709. doi: 10.1042/BST20140031

New strategies for cartilage regeneration exploiting selected glycosaminoglycans to enhance cell fate determination

2013

Journal Article

FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1

Dombrowski, Christian, Helledie, Torben, Ling, Ling, Grünert, Martin, Canning, Claire A., Jones, C. Michael, Hui, James H., Nurcombe, Victor, Van Wijnen, Andre J. and Cool, Simon M. (2013). FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1. Stem Cells, 31 (12), 2724-2736. doi: 10.1002/stem.1514

FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1

2013

Journal Article

MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma

Van Der Deen, Margaretha, Taipaleenmäki, Hanna, Zhang, Ying, Teplyuk, Nadiya M., Gupta, Anurag, Cinghu, Senthilkumar, Shogren, Kristen, Maran, Avudaiappan, Yaszemski, Michael J., Ling, Ling, Cool, Simon M., Leong, David T., Dierkes, Christian, Zustin, Jozef, Salto-Tellez, Manuel, Ito, Yoshiaki, Bae, Suk-Chul, Zielenska, Maria, Squire, Jeremy A., Lian, Jane B., Stein, Janet L., Zambetti, Gerard P., Jones, Stephen N., Galindo, Mario, Hesse, Eric, Stein, Gary S. and Van Wijnen, Andre J. (2013). MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma. Journal of Biological Chemistry, 288 (29), 21307-21319. doi: 10.1074/jbc.M112.445890

MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma

2013

Journal Article

Affinity-selected heparan sulfate for bone repair

Murali, S., Rai, B., Dombrowski, C., Lee, J. L.J., Lim, Z. X.H., Bramono, D. S., Ling, L., Bell, T., Hinkley, S., Nathan, S. S., Hui, J. H., Wong, H. K., Nurcombe, V. and Cool, S. M. (2013). Affinity-selected heparan sulfate for bone repair. Biomaterials, 34 (22), 5594-5605. doi: 10.1016/j.biomaterials.2013.04.017

Affinity-selected heparan sulfate for bone repair

2013

Journal Article

Telomere length analysis of human mesenchymal stem cells by quantitative PCR

Samsonraj, Rebekah M., Raghunath, Michael, Hui, James H., Ling, Ling, Nurcombe, Victor and Cool, Simon M. (2013). Telomere length analysis of human mesenchymal stem cells by quantitative PCR. Gene, 519 (2), 348-355. doi: 10.1016/j.gene.2013.01.039

Telomere length analysis of human mesenchymal stem cells by quantitative PCR

2013

Book Chapter

Heparanated surfaces

Nurcombe, Victor, Birch, William R. and Cool, Simon M. (2013). Heparanated surfaces. Handbook of Biofunctional Surfaces. (pp. 617-638) Boca Raton, FL United States: Pan Stanford Publishing.

Heparanated surfaces

2013

Journal Article

The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation

Bhakta, Gajadhar, Lim, Zophia X.H., Rai, Bina, Lin, Tingxuan, Hui, James H., Prestwich, Glenn D., Van Wijnen, Andre J., Nurcombe, Victor and Cool, Simon M. (2013). The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation. Acta Biomaterialia, 9 (11), 9098-9106. doi: 10.1016/j.actbio.2013.07.008

The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation

2012

Journal Article

Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2

Bhakta, Gajadhar, Rai, Bina, Lim, Zophia X.H., Hui, James H., Stein, Gary S., van Wijnen, Andre J., Nurcombe, Victor, Prestwich, Glenn D. and Cool, Simon M. (2012). Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials, 33 (26), 6113-6122. doi: 10.1016/j.biomaterials.2012.05.030

Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2

2012

Journal Article

Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow

Helledie, Torben, Dombrowski, Christian, Rai, Bina, Lim, Zophia X.H., Hin, Ian Lee Hock, Rider, David A., Stein, Gary S., Hong, Wanjin, Van Wijnen, Andre J., Hui, James H., Nurcombe, Victor and Cool, Simon M. (2012). Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow. Stem Cells and Development, 21 (11), 1897-1910. doi: 10.1089/scd.2011.0367

Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow

2012

Journal Article

Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces

Heng, Boon Chin, Li, Jian, Chen, Allen Kuan-Liang, Reuveny, Shaul, Cool, Simon M., Birch, William R. and Oh, Steve Kah-Weng (2012). Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces. Stem Cells and Development, 21 (10), 1701-1715. doi: 10.1089/scd.2011.0509

Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces

2012

Journal Article

Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2)

Bramono, Diah S., Murali, Sadasivam, Rai, Bina, Ling, Ling, Poh, Wei Theng, Lim, Zophia Xuehui, Stein, Gary S., Nurcombe, Victor, van Wijnen, Andre J. and Cool, Simon M. (2012). Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2). Bone, 50 (4), 954-964. doi: 10.1016/j.bone.2011.12.013

Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2)

2011

Journal Article

The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (ɛ-caprolactone)/collagen fibers and hyaluronic acid hydrogel

Ekaputra, Andrew K., Prestwich, Glenn D., Cool, Simon M. and Hutmacher, Dietmar W. (2011). The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (ɛ-caprolactone)/collagen fibers and hyaluronic acid hydrogel. Biomaterials, 32 (32), 8108-8117. doi: 10.1016/j.biomaterials.2011.07.022

The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (ɛ-caprolactone)/collagen fibers and hyaluronic acid hydrogel

2011

Journal Article

Multifunctional silica nanoparticles with potentials of imaging and gene delivery

Bhakta, Gajadhar, Sharma, Rakesh Kumar, Gupta, Nikesh, Cool, Simon, Nurcombe, Victor and Maitra, Amarnath (2011). Multifunctional silica nanoparticles with potentials of imaging and gene delivery. Nanomedicine: Nanotechnology, Biology, and Medicine, 7 (4), 472-479. doi: 10.1016/j.nano.2010.12.008

Multifunctional silica nanoparticles with potentials of imaging and gene delivery

2011

Journal Article

The effect of human bone marrow stroma-derived heparan sulfate on the Ex vivo expansion of human cord blood hematopoietic stem cells

Bramono, Diah S., Rider, David A., Murali, Sadasivam, Nurcombe, Victor and Cool, Simon M. (2011). The effect of human bone marrow stroma-derived heparan sulfate on the Ex vivo expansion of human cord blood hematopoietic stem cells. Pharmaceutical Research, 28 (6), 1385-1394. doi: 10.1007/s11095-010-0352-y

The effect of human bone marrow stroma-derived heparan sulfate on the Ex vivo expansion of human cord blood hematopoietic stem cells

2011

Journal Article

Comparative assessment of the effects of gender-specific heparan sulfates on mesenchymal stem cells

Murali, Sadasivam, Leong, Denise F. M., Lee, Jaslyn J. L., Cool, Simon M. and Nurcombe, Victor (2011). Comparative assessment of the effects of gender-specific heparan sulfates on mesenchymal stem cells. Journal of Biological Chemistry, 286 (20), 17755-17765. doi: 10.1074/jbc.M110.148874

Comparative assessment of the effects of gender-specific heparan sulfates on mesenchymal stem cells

2011

Journal Article

Defining a threshold surface density of vitronectin for the stable expansion of human embryonic stem cells

Yap, Lynn Y.W., Li, Jian, Phang, In Yee, Ong, Lay Ting, Ow, Jo'An Zhu-En, Goh, James C.H., Nurcombe, Victor, Hobley, Jonathan, Choo, Andre B.H., Oh, Steve K.W., Cool, Simon M. and Birch, William R. (2011). Defining a threshold surface density of vitronectin for the stable expansion of human embryonic stem cells. Tissue Engineering - Part C: Methods, 17 (2), 193-207. doi: 10.1089/ten.tec.2010.0328

Defining a threshold surface density of vitronectin for the stable expansion of human embryonic stem cells

Funding

Past funding

  • 2003
    DEVELOPMENT OF A NOVEL BIOMATERIAL FOR BONE TISSUE ENGINEERING
    ARC Discovery Projects
    Open grant
  • 2001
    Fibroblast growth factors and their effects on bone mesenchymal stem cells.
    UQ Early Career Researcher
    Open grant
  • 2000 - 2003
    Promotion of bone healing by exogenous applications of growth factors
    Wesley Merdical Research
    Open grant
  • 1999
    Fibroblast growth factor: unlocking the secrets of osteoblast growth, differentiation and apoptosis.
    UQ New Staff Research Start-Up Fund
    Open grant

Supervision

Availability

Professor Simon Cool is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Orthopaedic application of glycotherapeutics linked to implantable scaffolds

    We have developed a range of glycosaminoglycan compounds that drive cell fate decisions through complexation with protein/protein receptors that are important for bone formation. Here we seek to coat implantable scaffolds (doi: 10.1116/1.4933109) with these materials and to progress these implantable orthopaedic devices through a range of preclinical models in an effort to define their future clinical utility.

  • Age-related changes in stem cell glycosaminoglycans

    We have identified a range of glycosaminoglycan-altering enzymes that can potentially drive senescent phenotypes linked to stem cell ageing during scale-up manufacturing. Here we seek to develop glycosaminoglycan variants capable of replenishing these lost glycosaminoglycan structures that can restore growth and potency.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Professor Simon Cool's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au